Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Zucman

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Infectious Diseases|December 13, 2019
Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIVDominique Costagliola, Valérie Potard, Sylvie Lang, et al.
AIDS (London, England)|November 15, 2017
HIV is associated with airway obstruction: a matched controlled studyAlain Makinson, Maurice Hayot, Sabrina Eymard-Duvernay, et al.
Journal of Hepatology|March 9, 2016
Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis CAude Desnoyer, Dan Pospai, Minh Patrick Lê, et al.
Expert Review of Anti-Infective Therapy|February 4, 2021
Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH)Tangui Barré, Teresa Rojas Rojas, Karine Lacombe, et al.
HIV Medicine|January 7, 2026
Effectiveness and safety of two-drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor in a cohort of virologically suppressed people with HIV: Data from the COMBINE-2 studyCristina Mussini, Cassidy Henegar, Lambert Assoumou, et al.
International Journal of Radiation Oncology, Biology, Physics|June 24, 2024
Efficacy and Toxicity of (Chemo)Radiation Therapy in HIV+ Patients with Squamous Cell Anal Cancer, a Subgroup Analysis of the National Multicenter Cohort FFCD-ANABASECecile Evin, Laurent Quéro, Karine Le Malicot, et al.
Nature Communications|January 27, 2022
Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entryMathieu Claireaux, Rémy Robinot, Jérôme Kervevan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 2, 2024
Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: A French nationwide multicenter cohort study-ANRS0001s COV-POPARTPaul Loubet, Jean-Daniel Lelievre, Alexis François, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 3, 2022
Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohortJade Ghosn, Delphine Bachelet, Marine Livrozet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2016
All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH CohortPhilippe Sogni, Camille Gilbert, Karine Lacombe, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|December 13, 2019
Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIVDominique Costagliola, Valérie Potard, Sylvie Lang, et al.
AIDS (London, England)|November 15, 2017
HIV is associated with airway obstruction: a matched controlled studyAlain Makinson, Maurice Hayot, Sabrina Eymard-Duvernay, et al.
Journal of Hepatology|March 9, 2016
Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis CAude Desnoyer, Dan Pospai, Minh Patrick Lê, et al.
Expert Review of Anti-Infective Therapy|February 4, 2021
Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH)Tangui Barré, Teresa Rojas Rojas, Karine Lacombe, et al.
HIV Medicine|January 7, 2026
Effectiveness and safety of two-drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor in a cohort of virologically suppressed people with HIV: Data from the COMBINE-2 studyCristina Mussini, Cassidy Henegar, Lambert Assoumou, et al.
International Journal of Radiation Oncology, Biology, Physics|June 24, 2024
Efficacy and Toxicity of (Chemo)Radiation Therapy in HIV+ Patients with Squamous Cell Anal Cancer, a Subgroup Analysis of the National Multicenter Cohort FFCD-ANABASECecile Evin, Laurent Quéro, Karine Le Malicot, et al.
Nature Communications|January 27, 2022
Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entryMathieu Claireaux, Rémy Robinot, Jérôme Kervevan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 2, 2024
Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: A French nationwide multicenter cohort study-ANRS0001s COV-POPARTPaul Loubet, Jean-Daniel Lelievre, Alexis François, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 3, 2022
Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohortJade Ghosn, Delphine Bachelet, Marine Livrozet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2016
All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH CohortPhilippe Sogni, Camille Gilbert, Karine Lacombe, et al.
Pageof 8